Anti Hiv Medicines

Product Details:

Cronivir (Entecavir 0.5 mg) is an effective antiviral medication used for the treatment of chronic Hepatitis B virus (HBV) infection in adults with active viral replication and elevated liver enzymes. It belongs to the nucleoside analogue class and works by inhibiting HBV DNA polymerase, helping to reduce viral load, improve liver function, and prevent disease progression. Cronivir is well-recognized for its strong efficacy, high safety profile, and low resistance rate when taken as prescribed.

Manufactured under strict quality standards, Cronivir 0.5 mg ensures consistent therapeutic performance and stability. Each tablet is securely packaged to maintain purity, potency, and shelf life. It is typically taken once daily on an empty stomach or as directed by a healthcare professional. Cronivir is recommended for both treatment-naïve and lamivudine-resistant patients, offering a reliable long-term management option for chronic Hepatitis B.

This product is available for bulk supply, export, and domestic distribution. Genygi Life Sciences ensures prompt delivery, competitive pricing, and high-quality pharmaceutical-grade products. Suitable for hospitals, pharmacies, distributors, and tender requirements. Contact us for quotations, COA, regulatory support, and technical documentation.

Product Details:

Composition & Form

• Active Ingredient: Daclatasvir Dihydrochloride, 60 mg per film-coated tablet

• Form: Oral tablet, available in bottles of 28 tablets. 

• Manufacturer

   

  • Aprazer Healthcare (also marketed under Aprazer/Natco joint branding).

  • Therapeutic Indication

     

    • Indicated for the treatment of chronic Hepatitis C virus (HCV) infection

    • Should be administered in combination with Sofosbuvir (400 mg), typically for a 12‑week regimen.

    • Mechanism of Action

       

      • Direct‑acting antiviral (NS5A inhibitor) that disrupts HCV replication, reducing viral load and aiding liver recovery.

      • Dosage & Administration

         

        • One tablet (60 mg) orally once daily

        • Can be taken with or without food

        • For best results, take at the same time each day for the full prescribed duration—usually 12 weeks.

        • Key Benefits

           

          • Facilitates elimination of HCV, improving patients’ immune and liver health

          • Helps reduce the risk of progression to liver cirrhosis and hepatocellular carcinoma.

          • Precautions & Warnings

             

            • Prescription-only medication — ensure patient evaluation before dispensing

            • Monitor liver and kidney function during treatment.

            • Avoid use during pregnancy and breastfeeding unless clearly indicated; advised to use contraception

            • May cause side effects such as headache, dizziness, nausea, fatigue; avoid driving or operating machinery if affected

             

            • Caution with cardiac drugs like amiodarone and with CYP3A inducers/inhibitors.

            • Packaging & Storage

               

              • Bottles containing 28 tablets (60 mg)

              • Store at room temperature, protected from moisture and direct sunlight.

              • Trade & Export

                 

                • Supplied by Aprazer Healthcare

                • Export capacity supported, suitable for global markets including India, Middle East, Africa, Europe, and America.

Product Details:

Tenolam is a fixed-dose antiretroviral combination containing Tenofovir Disoproxil Fumarate (TDF) 300 mg and Lamivudine 300 mg, formulated to provide a reliable and effective treatment option for HIV-1 infection. This dual-therapy regimen helps reduce viral load, improve immune function, and prevent disease progression when used as part of a combination antiretroviral therapy (cART). Manufactured under strict quality and regulatory standards, Tenolam ensures high purity, consistent potency, and excellent therapeutic value.

Key Features:
• WHO-recommended first-line HIV treatment combination
• High-quality formulation with proven efficacy and safety
• Supports viral suppression and improved CD4 count
• Stable shelf life and robust packaging for export and domestic supply
• Suitable for government tenders, hospitals, NGOs, and large distributors

Packaging:
Available in bottles/boxes as per client requirement.

Indications:
For the treatment of HIV-1 infection in adults and adolescents, as prescribed by a healthcare professional.

Shelf Life: 24–36 months (depending on batch)
Compliance: Manufactured in WHO-GMP certified facilities.

Note: For bulk orders, price quotations, COAs, and regulatory documents, please contact us.

Product Details:

Product Name: Acriptega (Dolutegravir, Lamivudine, and Tenofovir Tablets 50mg/300mg/300mg)

Generic Name: Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate Tablets

Composition:

• Dolutegravir 50 mg

• Lamivudine 300 mg

• Tenofovir Disoproxil Fumarate 300 mg

Brand Name: Acriptega

Manufacturer: [Insert Manufacturer Name, e.g., ViiV Healthcare / Mylan Laboratories Ltd.]

Packaging: Bottle of 30 Tablets

Indication:
Acriptega is a fixed-dose combination antiretroviral medication used in the treatment of HIV-1 infection in adults and adolescents. It helps to reduce viral load, improve immune function, and delay progression of HIV infection.

Dosage:
As directed by a healthcare professional.

Key Features:

• Once-daily complete regimen for HIV-1 treatment

• High efficacy and good tolerability

• WHO-approved formulation

• Convenient fixed-dose combination

Storage:
Store below 30°C. Protect from moisture and direct sunlight.

Minimum Order Quantity (MOQ): [Insert MOQ, e.g., 1 Bottle / 100 Bottles]

Country of Origin: India